What development phase is Octyl Dimethyl Paba in?

Octyl Dimethyl Paba is FDA-approved (marketed).

What is the generic name of Octyl Dimethyl Paba?

Padimate O is the generic (nonproprietary) name of Octyl Dimethyl Paba.

Last reviewed 2026-04-20 · How we verify

Octyl Dimethyl Paba (Padimate O)

FDA-approved active Quality 6/100

At a glance

Generic name	Padimate O
Therapeutic area	Dermatology
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products (NA)
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products (NA)
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products (NA)
A Sunscreen Based on Bioadhesive Nanoparticles (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Octyl Dimethyl Paba CI brief — competitive landscape report
Octyl Dimethyl Paba updates RSS · CI watch RSS
portfolio CI